Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transperineal Laser Ablation for Low and Intermediate Risk Prostate Cancer: a Single Cohort Analysis

NCT05584787 is registered in ClinicalTrials.gov with San Carlo di Nancy Hospital as lead sponsor.

NCT NCT05584787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05584787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transperineal Laser Ablation for Low and Intermediate Risk Prostate Cancer: a Single Cohort Analysis
Lead sponsor
San Carlo di Nancy Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
May 1, 2021
Completion date
March 30, 2024
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer